| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.48B | 18.38B | 19.85B | 21.66B | 18.45B | 13.66B |
| Gross Profit | 12.03B | 18.38B | 19.85B | 21.66B | 18.45B | 13.66B |
| EBITDA | 7.09B | 6.79B | 7.28B | 5.84B | 6.04B | 3.59B |
| Net Income | 2.87B | 2.90B | 2.29B | 7.80B | 2.35B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 103.76B | 106.74B | 98.33B | 92.70B | 94.86B | 67.22B |
| Cash, Cash Equivalents and Short-Term Investments | 4.06B | 6.93B | 4.25B | 2.77B | 3.35B | 2.50B |
| Total Debt | 45.91B | 48.36B | 47.07B | 42.98B | 45.47B | 31.22B |
| Total Liabilities | 66.54B | 68.92B | 68.43B | 63.13B | 71.00B | 47.36B |
| Stockholders Equity | 37.19B | 37.80B | 29.87B | 29.54B | 23.83B | 19.84B |
Cash Flow | ||||||
| Free Cash Flow | -2.22B | -2.50B | -514.00M | 6.00M | 728.00M | -327.00M |
| Operating Cash Flow | 7.02B | 6.81B | 6.94B | 6.90B | 6.27B | 4.46B |
| Investing Cash Flow | -5.13B | -10.57B | -7.50B | 240.00M | -14.01B | -5.12B |
| Financing Cash Flow | -2.46B | 4.53B | 987.00M | -7.17B | 7.77B | 750.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £56.78B | 18.56 | 7.87% | 4.13% | -9.52% | 35.74% | |
73 Outperform | £20.81B | 17.45 | 9.92% | 2.85% | 1.78% | -50.72% | |
68 Neutral | £8.34B | 36.17 | 17.41% | 4.39% | 10.68% | 35.18% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | £8.21B | -35.94 | -5.95% | 2.86% | -4.82% | -123.58% | |
61 Neutral | £8.19B | 30.92 | 20.43% | 4.40% | 15.76% | 254.82% |